Voyager Therapeutics, Inc. (VYGR)
USD 3.64
(2.54%)
USD 3.64
(2.54%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 122.01 Million USD | 340.01% |
| 2022 | -50.83 Million USD | 30.94% |
| 2021 | -73.61 Million USD | -368.84% |
| 2020 | 27.38 Million USD | 152.99% |
| 2019 | -51.67 Million USD | 43.27% |
| 2018 | -91.09 Million USD | -26.76% |
| 2017 | -71.86 Million USD | -74.01% |
| 2016 | -41.29 Million USD | -103.91% |
| 2015 | -20.25 Million USD | -40.98% |
| 2014 | -14.36 Million USD | -90.75% |
| 2013 | -7.53 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -16.18 Million USD | -129.93% |
| 2024 Q2 | -15.02 Million USD | 7.16% |
| 2023 Q1 | 122.88 Million USD | 600.28% |
| 2023 Q3 | -29.5 Million USD | -16.05% |
| 2023 Q2 | -25.42 Million USD | -120.69% |
| 2023 Q4 | 54.06 Million USD | 283.22% |
| 2023 FY | 122.01 Million USD | 340.01% |
| 2022 FY | -50.83 Million USD | 30.94% |
| 2022 Q2 | -19.36 Million USD | 9.29% |
| 2022 Q3 | 14.44 Million USD | 174.57% |
| 2022 Q4 | -24.56 Million USD | -270.08% |
| 2022 Q1 | -21.35 Million USD | -474.43% |
| 2021 Q3 | -25.14 Million USD | 12.03% |
| 2021 FY | -73.61 Million USD | -368.84% |
| 2021 Q2 | -28.58 Million USD | -11.71% |
| 2021 Q1 | -25.58 Million USD | -7.84% |
| 2021 Q4 | 5.7 Million USD | 122.68% |
| 2020 Q2 | -8.98 Million USD | 63.24% |
| 2020 Q1 | -24.43 Million USD | -77.46% |
| 2020 Q3 | 84.52 Million USD | 1041.18% |
| 2020 Q4 | -23.72 Million USD | -128.07% |
| 2020 FY | 27.38 Million USD | 152.99% |
| 2019 Q2 | 9.18 Million USD | 131.37% |
| 2019 Q3 | -17.8 Million USD | -293.79% |
| 2019 Q4 | -13.76 Million USD | 22.68% |
| 2019 FY | -51.67 Million USD | 43.27% |
| 2019 Q1 | -29.29 Million USD | -26.48% |
| 2018 Q2 | -25.69 Million USD | -21.81% |
| 2018 FY | -91.09 Million USD | -26.76% |
| 2018 Q4 | -23.16 Million USD | -9.52% |
| 2018 Q3 | -21.14 Million USD | 17.7% |
| 2018 Q1 | -21.09 Million USD | -70.82% |
| 2017 Q1 | -17.52 Million USD | -26.59% |
| 2017 FY | -71.86 Million USD | -74.01% |
| 2017 Q4 | -12.34 Million USD | 47.13% |
| 2017 Q3 | -23.35 Million USD | -25.3% |
| 2017 Q2 | -18.63 Million USD | -6.37% |
| 2016 Q1 | -7.46 Million USD | -0.36% |
| 2016 FY | -41.29 Million USD | -103.91% |
| 2016 Q4 | -13.84 Million USD | -33.47% |
| 2016 Q3 | -10.37 Million USD | -7.83% |
| 2016 Q2 | -9.61 Million USD | -28.81% |
| 2015 Q1 | -4.82 Million USD | -7.38% |
| 2015 Q2 | -3.96 Million USD | 17.83% |
| 2015 FY | -20.25 Million USD | -40.98% |
| 2015 Q4 | -7.44 Million USD | -85.12% |
| 2015 Q3 | -4.01 Million USD | -1.31% |
| 2014 FY | -14.36 Million USD | -90.75% |
| 2014 Q2 | -3.23 Million USD | -8.21% |
| 2014 Q4 | -4.49 Million USD | -22.98% |
| 2014 Q3 | -3.65 Million USD | -13.19% |
| 2014 Q1 | -2.98 Million USD | 0.0% |
| 2013 FY | -7.53 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Absci Corporation | -115.51 Million USD | 205.626% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | 153.742% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 143.241% |
| Alzamend Neuro, Inc. | -9.93 Million USD | 1327.796% |
| Apollomics, Inc. | -54.83 Million USD | 322.515% |
| 180 Life Sciences Corp. | -13.47 Million USD | 1005.316% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | 488.864% |
| Bicycle Therapeutics plc | -189.94 Million USD | 164.236% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | 245.404% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | 171.028% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | 582.65% |
| Chimerix, Inc. | -93.06 Million USD | 231.106% |
| CRISPR Therapeutics AG | -222.53 Million USD | 154.828% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | -658.935% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | 265.64% |
| Fortress Biotech, Inc. | -142.34 Million USD | 185.719% |
| Fortress Biotech, Inc. | -142.34 Million USD | 185.719% |
| Gritstone bio, Inc. | -154.63 Million USD | 178.905% |
| Allakos Inc. | -196.05 Million USD | 162.234% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | 322.67% |
| Cara Therapeutics, Inc. | -121.49 Million USD | 200.427% |
| Cytokinetics, Incorporated | -496.2 Million USD | 124.589% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | 568.204% |
| Innoviva, Inc. | 176.7 Million USD | 30.952% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | 1686.196% |
| NLS Pharmaceutics AG | -11.8 Million USD | 1133.398% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | 196.027% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | 946316.113% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | 218.971% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | 237.301% |
| ImmuCell Corporation | -5.74 Million USD | 2222.692% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | 190.765% |
| Incyte Corporation | 620.52 Million USD | 80.337% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | 190.229% |
| Lexaria Bioscience Corp. | -6.53 Million USD | 1967.364% |
| Mustang Bio, Inc. | -50.72 Million USD | 340.535% |
| MiMedx Group, Inc. | 37.11 Million USD | -228.737% |
| MEI Pharma, Inc. | 14.54 Million USD | -739.046% |
| MacroGenics, Inc. | -168.24 Million USD | 172.522% |
| Monopar Therapeutics Inc. | -8.83 Million USD | 1481.619% |
| Mereo BioPharma Group plc | -28.41 Million USD | 529.385% |
| Marker Therapeutics, Inc. | -14.58 Million USD | 936.78% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | 192.797% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | 485.535% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | 627.752% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | 868.06% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | 1112.648% |
| NextCure, Inc. | -67.63 Million USD | 280.395% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | 336.893% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | 1255.107% |
| Onconetix, Inc. | -36.03 Million USD | 438.602% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | 392.501% |
| Opthea Limited | -191.84 Million USD | 163.601% |
| Ovid Therapeutics Inc. | -59.28 Million USD | 305.822% |
| Psyence Biomedical Ltd. | -2.75 Million USD | 4533.93% |
| PDS Biotechnology Corporation | -43.04 Million USD | 383.455% |
| Precigen, Inc. | -88.92 Million USD | 237.213% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | 510.048% |
| Prime Medicine, Inc. | -191.29 Million USD | 163.784% |
| PureTech Health plc | -146.19 Million USD | 183.457% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | 146.99% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 96.985% |
| Replimune Group, Inc. | -234.77 Million USD | 151.971% |
| Revelation Biosciences, Inc. | -8.65 Million USD | 1509.481% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | 695.452% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | 728.338% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 125.045% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | 601.979% |
| Sesen Bio, Inc. | -25.9 Million USD | 570.933% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 144.53% |
| Solid Biosciences Inc. | -104.31 Million USD | 216.967% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | 153.06% |
| SciSparc Ltd. | -5.77 Million USD | 2213.528% |
| Sutro Biopharma, Inc. | -89.27 Million USD | 236.667% |
| TG Therapeutics, Inc. | 20.63 Million USD | -491.354% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | 203.07% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | 1776.707% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 132.386% |
| UroGen Pharma Ltd. | -65.53 Million USD | 286.179% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | 285.547% |
| XOMA Corporation | -41.84 Million USD | 391.565% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | 149.004% |
| AbCellera Biologics Inc. | -237.2 Million USD | 151.438% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | 314.969% |
| Cassava Sciences, Inc. | -105.95 Million USD | 215.154% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | 370.677% |
| Precision BioSciences, Inc. | -43.73 Million USD | 378.978% |
| Dyadic International, Inc. | -8.22 Million USD | 1582.599% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | 1566.691% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | 10336.074% |
| VYNE Therapeutics Inc. | -29.25 Million USD | 517.028% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | 193.003% |
| IGM Biosciences, Inc. | -263.46 Million USD | 146.312% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | 213.478% |
| Acelyrin, Inc. | -422.06 Million USD | 128.909% |
| Abeona Therapeutics Inc. | -47.13 Million USD | 358.861% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | -921.722% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | 707.343% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | 256.018% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | 194.593% |
| Senti Biosciences, Inc. | -92.72 Million USD | 231.584% |
| Mesoblast Limited | -58.79 Million USD | 307.528% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | 173.711% |
| ChromaDex Corporation | -5.59 Million USD | 2279.211% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 2646.486% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | 363.78% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | 1617.227% |
| Seer, Inc. | -103.46 Million USD | 217.93% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | 377.242% |
| Novavax, Inc. | -566.51 Million USD | 121.538% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | 877.665% |
| Fate Therapeutics, Inc. | -190.51 Million USD | 164.046% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | 333.976% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | 149.7% |
| Celcuity Inc. | -66.23 Million USD | 284.227% |
| ContextLogic Inc. | -328 Million USD | 137.199% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | 172.926% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | 224.894% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 78.911% |
| Amarin Corporation plc | -67.58 Million USD | 280.526% |
| AnaptysBio, Inc. | -164.41 Million USD | 174.213% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | 522.515% |
| Aptorum Group Limited | -10.52 Million USD | 1259.462% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | 241.194% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | 159.518% |
| Ardelyx, Inc. | -63.27 Million USD | 292.828% |
| Celularity Inc. | -192.28 Million USD | 163.454% |
| Omeros Corporation | -164.53 Million USD | 174.159% |
| Humacyte, Inc. | -100.04 Million USD | 221.957% |
| Immunocore Holdings plc | -59.64 Million USD | 304.553% |
| IO Biotech, Inc. | -91.44 Million USD | 233.432% |
| GT Biopharma, Inc. | -13.57 Million USD | 998.748% |
| Cabaletta Bio, Inc. | -74.66 Million USD | 263.426% |
| Summit Therapeutics Inc. | -89.73 Million USD | 235.97% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | 456.069% |
| Pulmatrix, Inc. | -14.74 Million USD | 927.775% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 123.679% |
| Evogene Ltd. | -26.39 Million USD | 562.332% |
| CorMedix Inc. | -48.95 Million USD | 349.223% |
| BioLineRx Ltd. | -49.69 Million USD | 345.531% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | 469.504% |
| Sagimet Biosciences Inc. | -30.74 Million USD | 496.923% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 134.921% |
| scPharmaceuticals Inc. | -55.39 Million USD | 320.258% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | 210.256% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | -13.732% |
| NLS Pharmaceutics AG | -11.8 Million USD | 1133.398% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | 601.979% |
| Akero Therapeutics, Inc. | -172.87 Million USD | 170.581% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | 668.406% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | 574.615% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | 206.309% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | 246.911% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | 329.667% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | 745.656% |
| Daré Bioscience, Inc. | -30.83 Million USD | 495.637% |
| bluebird bio, Inc. | -244.26 Million USD | 149.952% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 37.249% |
| DBV Technologies S.A. | -76.43 Million USD | 259.637% |
| Avidity Biosciences, Inc. | -235.59 Million USD | 151.789% |
| Galecto, Inc. | -39.9 Million USD | 405.761% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | 429.198% |
| Spruce Biosciences, Inc. | -51.99 Million USD | 334.674% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | 155.658% |
| GlycoMimetics, Inc. | -39.27 Million USD | 410.664% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | 150.607% |
| ADMA Biologics, Inc. | 21.63 Million USD | -464.044% |
| Clene Inc. | -40.54 Million USD | 400.972% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 134.855% |
| Aptose Biosciences Inc. | -52.35 Million USD | 333.047% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | 946.099% |
| Soligenix, Inc. | -7.69 Million USD | 1685.021% |
| Century Therapeutics, Inc. | -146.54 Million USD | 183.26% |
| Kura Oncology, Inc. | -165.8 Million USD | 173.589% |
| Surrozen, Inc. | -45.78 Million USD | 366.522% |
| TScan Therapeutics, Inc. | -93.45 Million USD | 230.555% |
| Ocean Biomedical, Inc. | -2.48 Million USD | 5016.67% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | 1981.771% |
| Autolus Therapeutics plc | -195.02 Million USD | 162.562% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | 244.127% |
| Eterna Therapeutics Inc. | -21.13 Million USD | 677.308% |
| Caribou Biosciences, Inc. | -116.05 Million USD | 205.131% |
| GRI Bio, Inc. | -11.38 Million USD | 1171.52% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | 2801.986% |
| Janux Therapeutics, Inc. | -72.97 Million USD | 267.191% |
| INmune Bio, Inc. | -29.74 Million USD | 510.255% |
| Heron Therapeutics, Inc. | -110.61 Million USD | 210.305% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | 420.454% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | 863.572% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | 1581.842% |
| Jaguar Health, Inc. | -34.29 Million USD | 455.819% |
| Entero Therapeutics, Inc. | -15.77 Million USD | 873.669% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | 299.702% |
| Clearside Biomedical, Inc. | -24.84 Million USD | 591.121% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 144.207% |
| Coherus BioSciences, Inc. | -203.19 Million USD | 160.047% |
| Verastem, Inc. | -92.08 Million USD | 232.503% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | 166.26% |
| Histogen Inc. | -10.64 Million USD | 1246.425% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | 888.614% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | 266.279% |
| Surrozen, Inc. | -45.78 Million USD | 366.522% |
| Organovo Holdings, Inc. | -15.08 Million USD | 908.79% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | 2497.02% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | 1698.539% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | 171.235% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | 351.846% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | 901.628% |
| Kronos Bio, Inc. | -121.83 Million USD | 200.151% |
| Turnstone Biologics Corp. | -59.03 Million USD | 306.691% |
| Synaptogenix, Inc. | -8.31 Million USD | 1567.599% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | 936.514% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | 3958.76% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | 233.071% |
| Exelixis, Inc. | 170.88 Million USD | 28.599% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | 178.687% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 123.595% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | 277.189% |
| ESSA Pharma Inc. | -32.13 Million USD | 479.703% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | 812.572% |
| Avid Bioservices, Inc. | -18.67 Million USD | 753.25% |
| Insmed Incorporated | -709.62 Million USD | 117.194% |
| MediWound Ltd. | -15.29 Million USD | 897.999% |
| OmniAb, Inc. | -69.41 Million USD | 275.765% |
| Alector, Inc. | -151.74 Million USD | 180.41% |
| Seres Therapeutics, Inc. | -107.98 Million USD | 212.994% |
| Zai Lab Limited | -366.57 Million USD | 133.285% |
| AlloVir, Inc. | -181.33 Million USD | 167.288% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 138.517% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | 210.141% |
| Aura Biosciences, Inc. | -84.99 Million USD | 243.561% |
| Immunic, Inc. | -99.22 Million USD | 222.969% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | 185.23% |
| Veracyte, Inc. | -85.79 Million USD | 242.216% |
| InMed Pharmaceuticals Inc. | - USD | -Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 143.296% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | 958.649% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | -40.55% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | 1871.413% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | 749.266% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | 579.37% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | -214.453% |
| Fortrea Holdings Inc. | 63.1 Million USD | -93.366% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | 186.877% |
| XBiotech Inc. | -37.51 Million USD | 425.284% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | 277.189% |
| Keros Therapeutics, Inc. | -169.94 Million USD | 171.798% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | 422.2% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | 281.785% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | 213.074% |
| Agenus Inc. | -159.54 Million USD | 176.474% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | 575.28% |
| Theravance Biopharma, Inc. | -53.29 Million USD | 328.954% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 121.436% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | 255.448% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | 217.65% |
| Gain Therapeutics, Inc. | -22.25 Million USD | 648.3% |
| C4 Therapeutics, Inc. | -139.03 Million USD | 187.76% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | 2271.017% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | 579.257% |
| Lantern Pharma Inc. | -17.87 Million USD | 782.498% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | 383.753% |
| Ainos, Inc. | -13.2 Million USD | 1023.901% |
| Pluri Inc. | -22.15 Million USD | 650.654% |
| Prothena Corporation plc | -191.03 Million USD | 163.87% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | 188.392% |
| Rallybio Corporation | -78.93 Million USD | 254.581% |
| Kodiak Sciences Inc. | -277.32 Million USD | 143.997% |
| Cue Biopharma, Inc. | -52.14 Million USD | 333.972% |
| MeiraGTx Holdings plc | -137.06 Million USD | 189.022% |
| Annexon, Inc. | -143.72 Million USD | 184.895% |
| Assembly Biosciences, Inc. | -64.64 Million USD | 288.742% |
| Moderna, Inc. | -4.23 Billion USD | 102.878% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | 757.438% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | 598.362% |
| Blueprint Medicines Corporation | -486.27 Million USD | 125.091% |
| Immix Biopharma, Inc. | -16.14 Million USD | 855.921% |
| CalciMedica, Inc. | -21.87 Million USD | 657.778% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | 185.139% |
| Scholar Rock Holding Corporation | -171.29 Million USD | 171.23% |
| Wave Life Sciences Ltd. | -67.99 Million USD | 279.443% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 137.325% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | 441.346% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | 280.625% |
| Nutriband Inc. | -4.87 Million USD | 2604.43% |
| Protara Therapeutics, Inc. | -43.61 Million USD | 379.765% |
| Vor Biopharma Inc. | -126.03 Million USD | 196.809% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 97.124% |
| Alkermes plc | 414.12 Million USD | 70.537% |
| ProKidney Corp. | -151.52 Million USD | 180.526% |
| Applied Therapeutics, Inc. | -64.53 Million USD | 289.066% |
| Arcellx, Inc. | -89.88 Million USD | 235.752% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 120.089% |
| Tango Therapeutics, Inc. | -114.17 Million USD | 206.868% |
| Galectin Therapeutics Inc. | -38.07 Million USD | 420.482% |
| Atai Life Sciences N.V. | -125.47 Million USD | 197.245% |
| Renovaro Biosciences Inc. | -81.63 Million USD | 249.455% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | 249.878% |
| MediciNova, Inc. | -9.9 Million USD | 1332.432% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | 196.551% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | 1784.704% |
| GeoVax Labs, Inc. | -26.74 Million USD | 556.248% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | 152.632% |
| Biomea Fusion, Inc. | -126.13 Million USD | 196.733% |
| RenovoRx, Inc. | -11.39 Million USD | 1170.674% |
| Cullinan Oncology, Inc. | -191.08 Million USD | 163.852% |
| Geron Corporation | -193.94 Million USD | 162.912% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | 542.288% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | 208.104% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | 150.385% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | 584.259% |
| Royalty Pharma plc | 1.49 Billion USD | 91.823% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | 158.662% |
| Imunon, Inc. | -21.03 Million USD | 680.178% |
| BioAtla, Inc. | -129.68 Million USD | 194.083% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 137.229% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | 392.193% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | 171.371% |
| Structure Therapeutics Inc. | -102.77 Million USD | 218.72% |
| 89bio, Inc. | -151.2 Million USD | 180.695% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | 215.942% |
| aTyr Pharma, Inc. | -54.91 Million USD | 322.171% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | 239.561% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | 147.952% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | 1585.665% |
| Akari Therapeutics, Plc | -16.8 Million USD | 826.015% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | 1379875.937% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 63.856% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | 171.042% |
| Liquidia Corporation | -73.38 Million USD | 266.268% |
| Entera Bio Ltd. | -8.89 Million USD | 1472.332% |
| GH Research PLC | -41.22 Million USD | 395.992% |
| Vericel Corporation | -6.46 Million USD | 1987.593% |
| Arbutus Biopharma Corporation | -78.1 Million USD | 256.222% |
| Xencor, Inc. | -138.63 Million USD | 188.008% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | 2467.097% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | 863.572% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | 667.741% |
| Vaxcyte, Inc. | -468.04 Million USD | 126.069% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | 157.002% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | 974.527% |
| Lexaria Bioscience Corp. | -6.53 Million USD | 1967.364% |
| Portage Biotech Inc. | -18.25 Million USD | 768.46% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | 1784.704% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | 216.247% |
| OncoCyte Corporation | -25.13 Million USD | 585.415% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | 1179.306% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | 1164.968% |
| Purple Biotech Ltd. | 22.27 Million USD | -447.86% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | 518.472% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | 516.359% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | 166.184% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | 1724.255% |
| Moleculin Biotech, Inc. | -29.63 Million USD | 511.778% |
| United Therapeutics Corporation | 1.18 Billion USD | 89.703% |
| HilleVax, Inc. | -133.34 Million USD | 191.502% |
| Silo Pharma, Inc. | -3.85 Million USD | 3264.598% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3195.193% |
| Pharming Group N.V. | -4.87 Million USD | 2600.521% |
| Tharimmune, Inc. | -9.45 Million USD | 1390.441% |
| Genprex, Inc. | -31.07 Million USD | 492.636% |
| Apogee Therapeutics, Inc. | -93 Million USD | 231.194% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | 164.834% |
| Pyxis Oncology, Inc. | -82.19 Million USD | 248.443% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | 16049.542% |
| Virios Therapeutics, Inc. | -5.44 Million USD | 2340.055% |
| OKYO Pharma Limited | -15.74 Thousand USD | 774805.344% |
| Savara Inc. | -60 Million USD | 303.333% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 795.673% |
| Curis, Inc. | -48.33 Million USD | 352.45% |
| Carmell Therapeutics Corporation | -5.21 Million USD | 2438.652% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | 547.758% |
| BeiGene, Ltd. | -1.2 Billion USD | 110.103% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | 230.284% |
| Erasca, Inc. | -141.52 Million USD | 186.214% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | 2795.266% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | 2795.266% |
| Vincerx Pharma, Inc. | -42.6 Million USD | 386.357% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | 2018.459% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | 281.469% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | 178.952% |
| Cogent Biosciences, Inc. | -208.13 Million USD | 158.624% |
| Adicet Bio, Inc. | -152.03 Million USD | 180.252% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | 266.019% |
| Aditxt, Inc. | -26.06 Million USD | 568.161% |
| Adagene Inc. | -23.71 Million USD | 614.396% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 1769.116% |
| Quantum-Si incorporated | -111.17 Million USD | 209.753% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | 936.987% |
| Compugen Ltd. | -12.99 Million USD | 1039.147% |
| Generation Bio Co. | -138.56 Million USD | 188.057% |
| Astria Therapeutics, Inc. | -83.03 Million USD | 246.952% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | 241.122% |
| Invivyd, Inc. | -207.78 Million USD | 158.722% |
| Relay Therapeutics, Inc. | -373 Million USD | 132.712% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | 1400.996% |
| Spero Therapeutics, Inc. | 21.48 Million USD | -468.009% |
| Artelo Biosciences, Inc. | -10.28 Million USD | 1286.099% |
| 2seventy bio, Inc. | -216.7 Million USD | 156.305% |
| Instil Bio, Inc. | -159.16 Million USD | 176.657% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | 606.748% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | 3425.473% |
| GeoVax Labs, Inc. | -26.74 Million USD | 556.248% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | 432.173% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | 217.658% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | 171.656% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 117.83% |
| Evaxion Biotech A/S | -22.19 Million USD | 649.687% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | 248.108% |
| Verve Therapeutics, Inc. | -223.12 Million USD | 154.684% |
| Tyra Biosciences, Inc. | -79.94 Million USD | 252.622% |
| Cingulate Inc. | -22.75 Million USD | 636.109% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | -1528.59% |
| Unity Biotechnology, Inc. | -44.66 Million USD | 373.164% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | 296.562% |
| Clearmind Medicine Inc. | -8.74 Million USD | 1495.826% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | 260.132% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | 4260.062% |
| Viking Therapeutics, Inc. | -100.82 Million USD | 221.013% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 132.067% |
| ImmunityBio, Inc. | -362.25 Million USD | 133.682% |
| Korro Bio, Inc. | -84.53 Million USD | 244.337% |
| Kineta, Inc. | -15.72 Million USD | 876.022% |
| BioVie Inc. | -32.17 Million USD | 479.166% |
| Codexis, Inc. | -68.06 Million USD | 279.25% |
| Celularity Inc. | -192.28 Million USD | 163.454% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | 849.656% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | 154.811% |
| Virax Biolabs Group Limited | -6.49 Million USD | 1978.158% |
| Cibus, Inc. | -318.88 Million USD | 138.263% |
| IN8bio, Inc. | -30.33 Million USD | 502.195% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | 198.565% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | 620.449% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 134.494% |
| Eyenovia, Inc. | -25.4 Million USD | 580.248% |
| Puma Biotechnology, Inc. | 32.64 Million USD | -273.817% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | 2293.707% |
| Elevation Oncology, Inc. | -45.44 Million USD | 368.487% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | 254.189% |
| Cardiff Oncology, Inc. | -45.41 Million USD | 368.682% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | 188.927% |
| Regulus Therapeutics Inc. | -31.1 Million USD | 492.214% |
| Moolec Science SA | -6.65 Million USD | 1933.748% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | 299.571% |
| LAVA Therapeutics N.V. | -43.25 Million USD | 382.094% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | 174.325% |
| Compass Therapeutics, Inc. | -50.36 Million USD | 342.269% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | 1408.059% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | 657.277% |
| Humacyte, Inc. | -100.04 Million USD | 221.957% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | 252.266% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | 939.161% |
| Genelux Corporation | -24.16 Million USD | 604.92% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | 459.679% |
| Notable Labs, Ltd. | -14.65 Million USD | 932.462% |
| Immunovant, Inc. | -282.7 Million USD | 143.159% |
| Quantum-Si incorporated | -111.17 Million USD | 209.753% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | 673.725% |
| Vera Therapeutics, Inc. | -102.01 Million USD | 219.607% |
| Acasti Pharma Inc. | -11.31 Million USD | 1178.624% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | 632.322% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | 394.834% |
| PepGen Inc. | -84.76 Million USD | 243.942% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 632.882% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | 471.902% |
| Immuneering Corporation | -58.41 Million USD | 308.882% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | 2497.02% |
| Belite Bio, Inc | -31.66 Million USD | 485.291% |
| XOMA Corporation | -41.84 Million USD | 391.565% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | 280.708% |
| Bionomics Limited | -17.89 Billion USD | 100.682% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | -241.967% |
| uniQure N.V. | -282.87 Million USD | 143.134% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 1769.116% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | 194.216% |
| Forte Biosciences, Inc. | -32.48 Million USD | 475.589% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | 1568.499% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | 515.084% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | 2293.707% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | 958.649% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | 1472.64% |
| Altimmune, Inc. | -95.92 Million USD | 227.192% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | 266.891% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | -241.967% |
| Peak Bio, Inc. | -1356.23 USD | 8996656.631% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | 345.976% |
| Benitec Biopharma Inc. | -22.49 Million USD | 642.526% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 150.356% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | 510.186% |
| Zura Bio Limited | -62.63 Million USD | 294.792% |
| PolyPid Ltd. | -22.86 Million USD | 633.581% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | 510.186% |
| argenx SE | -425.04 Million USD | 128.706% |
| Immunome, Inc. | -109.53 Million USD | 211.398% |
| Verona Pharma plc | -67.83 Million USD | 279.88% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | 568.204% |
| Shattuck Labs, Inc. | -91.95 Million USD | 232.686% |
| CervoMed Inc. | -7.81 Million USD | 1661.7% |
| Plus Therapeutics, Inc. | -13.32 Million USD | 1015.952% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | 353.278% |
| Moolec Science SA | -6.65 Million USD | 1933.748% |
| Enveric Biosciences, Inc. | -16.44 Million USD | 841.797% |
| Design Therapeutics, Inc. | -78.19 Million USD | 256.048% |
| Leap Therapeutics, Inc. | -87.04 Million USD | 240.18% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | 401.277% |
| Achilles Therapeutics plc | -75.25 Million USD | 262.134% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | 4260.062% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | 320.047% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | 340.015% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | 284.593% |
| MoonLake Immunotherapeutics | -54.12 Million USD | 325.438% |
| Tourmaline Bio, Inc. | -45.4 Million USD | 368.7% |
| Beam Therapeutics Inc. | -176.48 Million USD | 169.136% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | 211.782% |
| AEON Biopharma, Inc. | -48.42 Million USD | 351.944% |
| Aadi Bioscience, Inc. | -71.93 Million USD | 269.622% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | 246.074% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | 1069.373% |
| NeurAxis, Inc. | -6.66 Million USD | 1930.806% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 126.493% |
| Lumos Pharma, Inc. | -36.61 Million USD | 433.244% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | -2266.304% |
| Palisade Bio, Inc. | -13.07 Million USD | 1033.542% |
| Nutriband Inc. | -4.87 Million USD | 2604.43% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | 268.437% |
| Neurogene Inc. | -55.58 Million USD | 319.517% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | 1535.29% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | 226.165% |
| Athira Pharma, Inc. | -125.46 Million USD | 197.249% |
| HCW Biologics Inc. | -25.71 Million USD | 574.446% |
| XOMA Corporation | -41.84 Million USD | 391.565% |
| Nektar Therapeutics | -137.42 Million USD | 188.786% |
| Arvinas, Inc. | -401.5 Million USD | 130.39% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | 1379875.937% |
| Merus N.V. | -156.54 Million USD | 177.941% |
| Omega Therapeutics, Inc. | -100.26 Million USD | 221.696% |
| Quince Therapeutics, Inc. | -34.62 Million USD | 452.438% |
| Rezolute, Inc. | -70.42 Million USD | 273.259% |
| Clene Inc. | -40.54 Million USD | 400.972% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | 844.966% |
| BeyondSpring Inc. | -23.11 Million USD | 627.879% |
| Synlogic, Inc. | -55.16 Million USD | 321.196% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | 780.54% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | 1227.254% |
| Peak Bio, Inc. | -1356.23 USD | 8996656.631% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | 401.247% |
| Krystal Biotech, Inc. | -109.72 Million USD | 211.198% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | 194.19% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 135.571% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | 2670.906% |
| MannKind Corporation | 8.67 Million USD | -1306.015% |
| Ikena Oncology, Inc. | -75.41 Million USD | 261.786% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | 1364.787% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | 281.487% |
| Gossamer Bio, Inc. | -183.75 Million USD | 166.399% |
| CohBar, Inc. | -12.38 Million USD | 1084.913% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | 340.545% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | 542.288% |
| Legend Biotech Corporation | -439.48 Million USD | 127.763% |
| Mural Oncology plc | -194.63 Million USD | 162.688% |
| Disc Medicine, Inc. | -91.12 Million USD | 233.897% |
| Champions Oncology, Inc. | -7.35 Million USD | 1758.7% |
| REGENXBIO Inc. | -268.12 Million USD | 145.506% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | 1238.383% |
| Anavex Life Sciences Corp. | -55.75 Million USD | 318.836% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | 413.172% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | 206.696% |
| Vaxart, Inc. | -83.34 Million USD | 246.393% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | 1532.088% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | 385.119% |
| Cellectis S.A. | -106.62 Million USD | 214.432% |
| Longeveron Inc. | -21.02 Million USD | 680.218% |
| Repare Therapeutics Inc. | -116.22 Million USD | 204.982% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | 145.558% |
| Inozyme Pharma, Inc. | -75.64 Million USD | 261.298% |
| Revolution Medicines, Inc. | -487.18 Million USD | 125.045% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | 1934.245% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | 377.595% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | 263.58% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | 275.219% |
| Anixa Biosciences, Inc. | -11.01 Million USD | 1208.11% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 97.167% |
| Denali Therapeutics Inc. | -196.69 Million USD | 162.031% |
| Revelation Biosciences, Inc. | -8.65 Million USD | 1509.481% |
| Veru Inc. | -93.78 Million USD | 230.104% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | 623.014% |
| Cingulate Inc. | -22.75 Million USD | 636.109% |
| Passage Bio, Inc. | -108.38 Million USD | 212.57% |
| Context Therapeutics Inc. | -25.07 Million USD | 586.642% |
| Exicure, Inc. | -14.99 Million USD | 913.644% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 159.212% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | 400.542% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | 1355.684% |
| Nuvalent, Inc. | -149.49 Million USD | 181.619% |
| ABVC BioPharma, Inc. | -8.21 Million USD | 1584.986% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | 237.51% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | 687.34% |
| OmniAb, Inc. | -69.41 Million USD | 275.765% |
| Anew Medical, Inc. | -1.3 Million USD | 9479.632% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | 1055.399% |
| Lipocine Inc. | -17.93 Million USD | 780.466% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | 278.089% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | 260.224% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | 420.454% |
| G1 Therapeutics, Inc. | -39.52 Million USD | 408.685% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | 645.095% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 121.042% |
| Ocugen, Inc. | -65.53 Million USD | 286.193% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | 229.987% |
| Q32 Bio Inc. | -92.1 Million USD | 232.477% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | 669.122% |
| Alumis Inc. Common Stock | -158.17 Million USD | 177.139% |
| Equillium, Inc. | -14.52 Million USD | 940.201% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | 295.516% |
| Coya Therapeutics, Inc. | -7.9 Million USD | 1643.827% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | 746.771% |
| Dominari Holdings Inc. | -21.79 Million USD | 659.8% |
| Edesa Biotech, Inc. | -9.22 Million USD | 1422.967% |
| vTv Therapeutics Inc. | -25.5 Million USD | 578.449% |
| Bio-Techne Corporation | 206.68 Million USD | 40.966% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 131.167% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 36.461% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | 192.241% |
| Candel Therapeutics, Inc. | -38.39 Million USD | 417.819% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 180.75% |
| Nkarta, Inc. | -131.65 Million USD | 192.681% |
| BioCardia, Inc. | -11.64 Million USD | 1147.87% |
| Iterum Therapeutics plc | -47.46 Million USD | 357.045% |